Cite
APA Citation
Rosenkranz, S., Channick, R., Chin, K. M., Jenner, B., Gaine, S., Galiè, N., Ghofrani, H., Hoeper, M. M., McLaughlin, V. V., Du Roure, C., Rubin, L. J., Sitbon, O., Tapson, V., & Lang, I. M. (2022). the impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study. European journal of heart failure, 24, 205–214. http://access.bl.uk/ark:/81055/vdc_100150598410.0x00002b